In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
501 News Items found
Family of four sitting and smiling for camera.
Metastatic Breast Cancer and Motherhood

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Bowl of lemons, onion, orange, and red peppers.
Breast Cancer, Food, and Diet: Tips From an MSK Expert

Learn diet and food tips that can lower the risk of breast cancer and potentially improve the outcome if cancer is diagnosed, from Neil Iyengar, an expert on diet and cancer at Memorial Sloan Kettering.
MSK patient receiving chemotherapy
In the Clinic
6 Breakthroughs That Are Changing Chemotherapy for People with Breast Cancer

Discover some of the latest innovations in chemotherapy for breast cancer.
MSK Physician-in-Chief José Baselga presents at the ASCO meeting
Finding
Targeted Therapy Slows Growth of Most Common Type of Advanced Breast Cancer

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.
A woman considering birth control pills
Feature
Birth Control and Cancer Risk: 6 Things You Should Know

Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.
MSK breast cancer specialist Pedram Razavi, MD, PhD.
Article
Latest Research Into Overcoming Resistance to Breast Cancer Targeted Therapies

Learn how MSK's researchers are making important strides in overcoming breast cancer resistance.
Dr. Shanu Modi speaks with a patient
In the Clinic
FDA Approves Trastuzumab Deruxtecan (T-DXd) for Early-Stage HER2-Positive Breast Cancer

The FDA has approved trastuzumab deruxtecan (T-DXd, Enhertu) for treating early-stage, HER2-positive breast cancer based in part on clinical research led by MSK breast medical oncologist Shanu Modi, MD.
Monica Morrow
Feature
MSK Researchers Target Side Effects More Common in Black Women with Breast Cancer

MSK researchers are studying why Black patients with breast cancer are more likely to experience heart problems that can result from treatment.
Image of dividing breast cancer cells taken with electron microscope.
In the Lab
Researchers Identify Why Women May Develop Resistance to a New Class of Breast Cancer Drugs

Clues emerge about why promising new breast cancer drugs sometimes don’t work — and what might be done about it.
Radiologist Maxine Jochelson
Finding
Imaging and Artificial Intelligence Tools Help Predict Response to Breast Cancer Therapy

For HER2-positive breast cancers, MRI scans that employ machine-learning algorithms can provide more guidance than biopsies alone.